• BX Home
  • Johnson & Johnson: News [Page 5]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

JOHNSON & JOHNSON

Johnson & Johnson is a global pharmaceutical, medical devices and consumer packaged goods manufacturer. Founded in 1886, J&J now includes about 250 subsidiaries in more than 57 countries. A household name in the U.S., the company’s products are sold in more than 175 countries. The topic covers Johnson & Johnson the company, its products and market updates.

Johnson & Johnson is part of Business Exchange, suggested by Carlton St Bernard. This topic contains 1,302 news and 1,890 blog items. Read updated news, blogs, and resources about Johnson & Johnson. Find user-submitted articles and reactions on Johnson & Johnson from like-minded professionals.

News

Please add new articles to this topic

Boston Scientific Wins $19.5 Million in Patent Disputemore

shares were down three cents to $6.99 in midday trading Wednesday on the New York Stock Exchange. J&J rose 74 cents...

J&J, Hip Makers Asked by FDA for Patient Data on Metal in Bloodmore

May 11 (Bloomberg) -- The U.S. Food and Drug Administration asked Johnson & Johnson, which is already facing more...

Boston Scientific Wins $19 Million Stent Damages From Cordismore

Corp., which makes coronary stents to repair clogged arteries, won more than $19 million in patent-infringement damages...

HIV drug recalled for musty odormore

Johnson & Johnson is again recalling a prescription drug because of an odd musty odor likely caused by a chemical...

Commodities Turn South, Stocks Following Suit, Dow Down 100-plusmore

3%. Staples and drugmakers, classic safety/slow-growth plays are doing better. Kraft, Coke, Procter & Gamble,...

Wednesday's ETF to Watch: iShares MSCI Israel Fundmore

Database. All content on ETF Database is produced independently of any advertising relationships. Read the full...

J&J Recalls HIV Drugmore

recall HIV/AIDS drug Prezista in several countries after discovering trace amounts of a chemical that emitted offensive...

J&J, Hip Makers Asked by FDA for Data on Metal in Patientsmore

May 11 (Bloomberg) -- The U.S. Food and Drug Administration asked Johnson & Johnson, which is already facing more...

Another J&J recall over musty odor, for HIV drugmore

NEW BRUNSWICK, N.J. ? Johnson & Johnson is again recalling a prescription drug because of an odd musty odor likely...

Goldman on Johnson & Johnson: ���Buy���more

Goldman Sachs analysts punched the buy button on Johnson & Johnson. The stock has been on something of a tear...

A.M. Vitals: Appeals Court Questions Virginia's Standing in Health-Law...more

law is ; appeals courts in other states will hear arguments in June. Keeping Tabs: The FDA has asked Johnson &...

U.S. Stock Futures Little Changed Before Data; J&J Advancesmore

Index rose for a third day yesterday, as investors awaited a report on the nation���s trade deficit. Johnson &...

A.M. Vitals: Appeals Court Questions Virginia���s Standing in Health-L...more

of several ; appeals courts in other states will hear arguments in June. Keeping Tabs: The FDA has asked Johnson &...

FDA Asks Metal Hip Makers J&J, Zimmer for Patient Datamore

May 10 (Bloomberg) -- Johnson & Johnson, already facing more than 1,000 lawsuits over hip replacements, was asked...

FDA Asks Metal Hip Makers J&J, Stryker for Patient Datamore

May 10 (Bloomberg) -- Johnson & Johnson, already facing more than a thousand lawsuits over hip replacements, was...

J&J Books Reserve in Risperdal Probemore

specify the size of the reserve it booked in the first quarter for a potential Risperdal settlement. A J&J...

FDA Asks Makers of Metal Hip Replacements to Provide Datamore

provide data on ion concentrations and ���adverse events��� associated with the devices. Companies that received the...

What Zipcar Can Teach the S&P 500more

reasonthey fail very fast and very cheaply. What could happen if these companies embraced the venture capitalist...

Alkermes Gains on Plan to Buy Elan Division for $960...more

the body. Alkermes makes a long-lasting injection of a schizophrenia therapy called Risperdal Consta which it developed...

Antipsychotic Drugs Called Hazardous for the Elderlymore

chain for nursing homes, paid $98 million in November 2009 to settle accusations that it received kickbacks from...

J&J's Remicade meets ulcerative colitis study goalmore

Johnson & Johnson said Monday that its drug Remicade met key goals in treating pediatric patients with moderate to...

In Biotech, Two Platforms Are Better Than Onemore

Nasdaq: ALKS The fit seems perfect for Alkermes, which also has an extended-release platform. It receives royalties...

Elan to sell drug unit in ��590m dealmore

Extract not available.

Alkermes Gains on Plans to Buy Elan Division for $960 Millionmore

the body. Alkermes makes a long-lasting injection of a schizophrenia therapy called Risperdal Consta which it developed...

TriReme Medical Lines Up Asian Strategy With Key Appointment Of New Bo...more

and CEO of Bose Consulting Group, is based in Singapore and was until recently Company Group Chairman at Johnson &...

Top Sources: Johnson & Johnson

  • Financial Times
  • BusinessWeek
  • Reuters
  • Motley Fool
  • TheStreet.com
  • thedeal.com
  • New York Times
  • Wall Street Journal Online
  • MarketWatch
  • youtube.com

Most Active Users in this Topic

see all contributors in Johnson & Johnson

Featured White Papers

Post a Job

Jobs in this Topic

Retail Store Manager / Houston NorthWest / J D T-Mobile | Houston, TX
Posted: May 25
ACCOUNT MANAGER CALGARY (J DIS5) Pitney Bowes | Alberta, VA
Posted: Apr 28
Assurance Senior Associate Core Audit (Johnson City PwC | Franklin, TN
Posted: Mar 9

Report comment contains invalid characters. ()
cancel
Search Cancel